Fibrolamellar Cancer Foundation
Scientific Advisory Board
FCF strives to be in the forefront of research on fibrolamellar hepatocellular carcinoma. Several leading physicians, scientists and researchers in this field have agreed to be on FCF's Scientific Advisory Board. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer.
|
|
Sanford M. Simon, PH.D. Professor Head, Laboratory of Cellular Biophysics The Rockefeller University, New York |
|
|
|
Ronald P. DeMatteo, M.D., FACS |
|
|
|
Ron Levine, M.D. |
|
|
|
Lola Reid, PH.D. |
|
|
|
|
|
.jpg) |
Alan P. Venook, M.D. |
|
 |
Michael Choti, M.D., M.B.A. |
|
 |
Michael P. LaQuaglia, MD, FACS, FRCS |
| Header photos: (L to R) One of the custom-designed microscopes in the Cellular Biophysics Lab at Rockefeller University; FCF Scientific Advisory Board Chairman, Dr. Sandy Simon explains how antibodies can be targeted to malignant cells |
Announcements
Welcome
Welcome to our new website. We hope you find it interesting and informative. This is our modest beginning to develop this site into all things fibrolamellar, a place for patients, doctors, researchers and donors to help fight this killer cancer.
FCF Ambassadors
...are doing interesting and innovative things to raise money for the Foundation. Check it out.